Intelicare Holdings (ICR) Fair Value & Analysis

Healthcare · AU · Market cap A$20.0M

Below-average quality, trading 17% below our fair value.

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

What matters now

• Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
• Our model range runs from A$0.0264 (bear) to A$0.0438 (bull), base A$0.0351. The closer the price sits to the lower half, the larger the margin of safety.
• Quality 37/100 (below-average quality) with low evidence: read the verdict with care.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 26, 2026.

How to read this chart

60‑month range A$0.0050 – A$0.2300 · fair‑value band A$0.0264 – A$0.0438 · the A$0.0290 price screens below the A$0.0351 fair value. Dashed = 300-day average. As of Aug 26, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Intelicare Holdings (ICR) currently trades at A$0.0290, while our model-based Fair Value estimate is A$0.0351, implying the stock looks roughly 21.0% undervalued today. The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

Trailing-twelve-month revenue stands at A$945K. Revenue declined 2.3% year over year. Fundamentals as of Aug 26, 2026

Our scenario range runs from A$0.0264 (bear case) to A$0.0438 (bull case); at A$0.0290, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 17% below its 52-week high, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -64% fair-value upside, at 21%, ICR screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Key figures & financial health

Quality Score breakdown

About the company

Intelicare Holdings Limited engages in the research, development, and sale of predictive analytics hardware and software package for use in the aged care, disability, and health industries in Australia.

Full company description

Intelicare Holdings Limited engages in the research, development, and sale of predictive analytics hardware and software package for use in the aged care, disability, and health industries in Australia. The company offers a smart home and predictive analytics platform for caregivers to track activity levels, patterns of behavior, health metrics, sleep, and others to detect and help prevent incidents, emergencies, and health issues. It also provides hardware solutions, such as smart home sensors; a two-way voice hub that sends instant emergency alert to caregivers or a duress call triage service; emergency and incident detection devices, including pendants and panic buttons; and vitals and health metrics devices. In addition, the company offers a smart platform for access to 24/7 live health and wellbeing data. Additionally, it engages in sales and marketing, and research and development activities. Intelicare Holdings Limited was founded in 2016 and is based in Leederville, Australia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Intelicare Holdings reported revenue of A$957K in FY2025 versus A$363K in FY2021, a compound +27.4%/yr. Reported net income was −A$2.2M in FY2025.

Watch ICR: get an alert when its fair value changes →

Peer Group

Health Information Services · 128 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Health Information Services median · lower = cheaper

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Aug 26, 2026).

Explore undervalued stocks

More undervalued Healthcare stocks →

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

Discover tools

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.